Major price cut announced for critical drug for resistant TB (By: Chris Dall, MA)
A core component of the treatment regimen for drug-resistant tuberculosis (DR-TB) is now available to nearly 100 low-resources countries at a significantly cheaper price. The news was announced today by the Stop TB Partnership, which said pharmaceutical…